Search Results: node/Dendreon
Washington’s Health Care System Includes a Vibrant Tech Sector
Outstanding Achievement in Biopharmaceuticals (in alphabetical order) Ryo Kubota Chairman, president and CEO, Acucela Inc. It wasnt enough to discover the first glaucoma gene; Ryo Kubota founded Acucela Inc. on the notion that some eye diseases, including what is called age-related macular degeneration, or AMD, could be slowed down. His innovative new approach, which is…
Paradigm Shift
Dendreon exploded into national prominence in 2010 for bringing its research discovery, Provenge, into commercial use after receiving Food and Drug Administration approval in April. Provenge is a breakthrough therapy that uses a patients own cells to fight prostate cancer. One expert in the field, Philip Kantoff of the Dana-Farber Cancer Institute, said Provenge will…
Dendreon Wins Approval for Provenge
Finally, might be the word of the day for the nearly 500 employees of Seattle biotechnology powerhouse Dendreon, which won approval Thursday from the FDA for its therapeutic vaccine Provenge. The treatment is for men with prostate cancer that has not responded to other therapy. The company has spent 15 years working towards this goal….
Join The Must List
Sign up and get Seattle's best events delivered to your inbox every week.